CRH and cancer: Functional alterations of the HPA axis are a common phenomenon in patients with cancer, characterized mainly by elevated corticotropin-releasing hormone (CRH) secretion adrenocorticotropic hormone(ACTH), which leads to abnormally high levels of glucocorticoid and catecholamine.